University of St. Thomas, Minnesota

UST Research Online
Chemistry Faculty Publications

Chemistry

2020

Identification of a Novel Plasmid-Borne Gentamicin Resistance
Gene in Nontyphoidal Salmonella Isolated from Retail Turkey
Justin J. Donato
University of St. Thomas, Minnesota

Happy-Sarah L. Kim
Ricardo D. Rodriguez
Sydney K. Morris
Shaohua Zhao

Follow this and additional works at: https://ir.stthomas.edu/cas_chem_pub

Recommended Citation
Donato, Justin J.; Kim, Happy-Sarah L.; Rodriguez, Ricardo D.; Morris, Sydney K.; and Zhao, Shaohua,
"Identification of a Novel Plasmid-Borne Gentamicin Resistance Gene in Nontyphoidal Salmonella Isolated
from Retail Turkey" (2020). Chemistry Faculty Publications. 65.
https://ir.stthomas.edu/cas_chem_pub/65

This Article is brought to you for free and open access by the Chemistry at UST Research Online. It has been
accepted for inclusion in Chemistry Faculty Publications by an authorized administrator of UST Research Online.
For more information, please contact asle4660@stthomas.edu.

EPIDEMIOLOGY AND SURVEILLANCE
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ABSTRACT The spread of antibiotic-resistant bacteria presents a global health challenge. Efﬁcient surveillance of bacteria harboring antibiotic resistance genes (ARGs)
is a critical aspect to controlling the spread. Increased access to microbial genomic
data from many diverse populations informs this surveillance but only when functional ARGs are identiﬁable within the data set. Current, homology-based approaches are effective at identifying the majority of ARGs within given clinical and
nonclinical data sets for several pathogens, yet there are still some whose identities
remain elusive. By coupling phenotypic proﬁling with genotypic data, these unknown ARGs can be identiﬁed to strengthen homology-based searches. To prove the
efﬁcacy and feasibility of this approach, a published data set from the U.S. National
Antimicrobial Resistance Monitoring System (NARMS), for which the phenotypic and
genotypic data of 640 Salmonella isolates are available, was subjected to this analysis. Six isolates recovered from the NARMS retail meat program between 2011 and
2013 were identiﬁed previously as phenotypically resistant to gentamicin but contained no known gentamicin resistance gene. Using the phenotypic and genotypic
data, a comparative genomics approach was employed to identify the gene responsible for the observed resistance in all six of the isolates. This gene, grdA, is harbored on a 9,016-bp plasmid that is transferrable to Escherichia coli, confers gentamicin resistance to E. coli, and has never before been reported to confer gentamicin
resistance. Bioinformatic analysis of the encoded protein suggests an ATP binding
motif. This work demonstrates the advantages associated with coupling genomics
technologies with phenotypic data for novel ARG identiﬁcation.
KEYWORDS antibiotic resistance, comparative genomics, gentamicin

B

acteria play an essential role in maintaining balance in various ecosystems, including the human gut, marine ecosystems, and soil (1–3). Despite their contributions
to maintaining ecological balance, pathogenic bacteria are also responsible for some of
the most devastating infections in humans, animals, livestock, and crops. The development of antibiotics was a medical breakthrough that saved lives, with an estimated
47 million courses of antibiotics prescribed in a clinical setting per year (4). Unfortunately, the long-term use and misuse of this class of medication has led to a new crisis,
i.e., antibiotic resistance.
Historically, reliance on antibiotics has had both positive and negative effects: they
provide the means to control the spread of bacterial infections, and they serve as a
selective pressure for the development of single-drug- and multidrug-resistant pathogens. Currently, there are efforts to encourage more responsible management of
antibiotics, including limiting their access, use, and disposal.
Another effort complementary to responsible drug use is systematic surveillance of
antibiotic resistance through standard susceptibility testing and genomic surveillance
of antibiotic resistance genes (ARGs). The large amount of data from genomic surveilNovember 2020 Volume 64 Issue 11 e00867-20
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lance is making it possible to discover novel ARGs and to elucidate the mechanisms of
resistance, which contributes to the development/discovery of improved antimicrobial
agents. These initiatives rely on the ability to recognize ARGs within genomic information. Therefore, comprehensive catalogs of known ARGs need to constantly be updated
with novel ARGs as they are discovered. This strategy poses challenges in that the
quality of the analysis is completely dependent on the completeness of the data in
the database (5). This approach also suffers from the potential limitation of reliance on
the need to coordinate sequence data with phenotypic data for conﬁrmation of novel
resistance mechanisms. Advances in next-generation sequencing technologies have
aided in implementation of these surveillance strategies. To effectively identify novel
ARGs, there are challenges within available and currently practiced methods that need
to be overcome, including reliance on homology-based searches commonly used in
sequence-based methods, repeated identiﬁcation of known genes seen in phenotypebased methods, and detection of novel ARGs that are masked by the existence of
known ARGs within the same isolate (6).
Although current databases contain many known ARGs, and the correlation between clinical resistance and the presence of known ARGs is high, resistance is found
in some isolates with no known determinant in the databases (7, 8). This suggests that
there are unknown genes responsible for the unexplained and unpredicted resistance
hidden among the thousands of known ARGs. These instances offer an opportunity for
candidate genes to be characterized for previously unrecorded antibiotic resistance
potential. A number of research groups have compiled data on the genotypes and
phenotypes for many of the notorious pathogenic bacterial species, including Salmonella enterica, Staphylococcus aureus, Klebsiella pneumoniae, Campylobacter jejuni, Escherichia coli, Enterococcus, Acinetobacter baumannii, and Mycobacterium tuberculosis,
making the whole-genome sequencing (WGS) data for these and similar studies
accessible (7–12). Within these data, a subset of isolates exists that are phenotypically
resistant to a given antibiotic but for which no known ARG is identiﬁable in the
genome. These are termed GSPR (genotypically sensitive, phenotypically resistant)
isolates and serve as potential candidates for novel ARG discovery.
In this work, a comparative genomics approach was employed to predict novel ARGs
from GSPR isolates in a given collection. As a proof-of-concept experiment, 640
Salmonella isolated from the U.S. National Antimicrobial Resistance Monitoring System
(NARMS) were analyzed (7). That data set contained 6 isolates that were classiﬁed GSPR
with respect to their gentamicin resistance proﬁle. One potential ARG was found to be
common to all 6 GSPR isolates. On cloning and introduction into E. coli, the gene
conferred resistance to gentamicin. To our knowledge, this is the ﬁrst report of that
gene being associated with antibiotic resistance and accounts for the observed resistance in the 6 original isolates.
RESULTS
The goal of this study was to identify novel ARGs while avoiding the challenges
associated with rediscovery of known ARGs within a sample set of interest. A comparative genomics approach was employed to isolate potential candidate novel ARGs of
interest. A previously reported, publicly available data set containing both WGS and
antibiotic resistance phenotypic data for 640 Salmonella isolates was used to validate
this method (7). The WGS data were downloaded and subjected to the computational
analysis outlined in Fig. S1 in the supplemental material. The assembled genomic
sequences were ﬁrst annotated with Prokka and then used to construct a pangenome
of all isolates in the data set with Roary. The isolates were then grouped according to
their phenotypic and genotypic resistance proﬁles. Six isolates from the group formed
a subgroup, categorized as GSPR with respect to their gentamicin resistance proﬁles.
Because they were genotypically sensitive (contained no known gentamicin resistance
gene) and phenotypically resistant (growing in the presence of gentamicin), this
subgroup was used to query the Salmonella pangenome. Genetic features that distinguish this subset from the set of gentamicin-susceptible isolates are likely to confer
November 2020 Volume 64 Issue 11 e00867-20
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gentamicin resistance. The relevant portion of the output of this analysis is shown in
Table S1 in the supplemental material. All six isolates contained two genes that were
linked on the same contig and did not appear in the set of susceptible isolates. One
gene encodes a predicted IS30 family transposase, and the other encodes a hypothetical protein. The gene encoding the hypothetical protein was hypothesized to be
responsible for conferring the gentamicin resistance and has been named gentamicin
resistance determinant, or grdA.
The predicted protein encoded by grdA was used in a BLASTp search of GenBank.
The only matches in the database that were 100% identical to this protein at the amino
acid level were from Salmonella (accession no. EAA2172449.1, EAA8537079.1, and
WP_052905207.1). Two of these proteins are annotated as hypothetical proteins, and
the third is predicted to be an AAA family ATPase. The translated product contained
matches to the Walker A motif characteristic of ATP binding (see Fig. S2 in the
supplemental material). Amino acid residues 7 to 14 (GPLGIGKS) ﬁt the consensus for
the Walker A element (GxxxxGK[S/T]) (13). No other potential biochemical activity was
attributed to this protein based on the bioinformatic analysis.
To independently verify that grdA encodes a gentamicin resistance gene, total DNA
from one of the six GSPR isolates was analyzed (isolate N46855). To test whether the
unknown gentamicin resistance gene from this isolate is harbored on a plasmid, a
sample of the total DNA was used to transform E. coli. The resulting transformants grew
on medium supplemented with gentamicin, conﬁrming the transfer of a plasmid-borne
resistance gene to E. coli. The gene on the plasmid responsible for the resistance was
identiﬁed through transposon mutagenesis. Three independent transposon insertions
were isolated that restored sensitivity to gentamicin. Two of three transposons were
inserted into the coding sequence of a single genetic element (Fig. S2). That genetic
element is the same grdA gene that was identiﬁed through the computational analysis.
The remaining transposon insertion that restored gentamicin sensitivity inserted between the open reading frame and the promoter of grdA and likely disrupted expression of the gene.
The sequence of the entire plasmid from the transformation of strain N46855,
named pZJ18, was assembled by sequencing individual random transposon insertions
and assembling them with contigs from the original published data set. The resulting
sequence revealed a 9,016-bp Col-type plasmid that contains two regions with homology to known sequences (Fig. 1). The ﬁrst region is 100% identical via BLASTn to a
plasmid (GenBank accession no. CP044113.1) isolated from multiple bacteria, including
Klebsiella michiganensis and Salmonella enterica. The following regions of pZJ18 together span this entire plasmid sequence: 5089-59. pZJ18 appears to be a version of
this plasmid that has gained a transposon, with the segment containing the transposon
(pZJ18 nt 60 – 4970) 99% identical to a region of the S. enterica chromosome (GenBank
accession no. CP043222.1). The genes harbored on pZJ18 are depicted in Fig. 1 and
encode the following predicted proteins: three transposases, factors involved in plasmid maintenance, two lipoproteins, and GrdA. pZJ18 also contains a repeated sequence. The regions containing nucleotides (nt) 60 to 1443 and 3587 to 4970 differ by
one nucleotide. To rule out an assembly error, the plasmid was puriﬁed from E. coli and
subjected to restriction fragment analysis. The banding pattern that veriﬁed the
assembled sequence matched the observed restriction pattern, indicating that the
repeated region is present on the plasmid (data not shown).
Because the sequence ﬂanking grdA suggests that it is present on a mobile genetic
element, it is possible that that gene is present in other genetic contexts. In that case,
this data set would contain isolates that harbor grdA but do not have pZJ18. To test this,
total DNA from each of the other ﬁve GSPR isolates was used to transform E. coli and
was selected for gentamicin-resistant colonies. None were found, suggesting that
pZJ18 was not present in any of those samples. To test this bioinformatically, a BLAST
database was created from all of the isolates in this data set. That database was queried
ﬁrst for sequences matching grdA. Eight total isolates have this gene. All eight of these
isolates were originally reported to be resistant to gentamicin. Six of them are the six
November 2020 Volume 64 Issue 11 e00867-20
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GSPR isolates used in this study. The remaining two isolates (N31844 and N51292)
harbor known gentamicin resistance genes in addition to grdA, which led to their not
being classiﬁed as genotypically sensitive. The second query of this BLAST database was
performed using the region of pZJ18 from nt 5089-50. This is the region that contains
known plasmid sequences but does not contain the transposon bearing grdA. Two
isolates contain this sequence. One is the GSPR isolate detailed in this study. The
second (N45398) does not contain the grdA gene and does not display any phenotypic
resistance to gentamicin. All plasmids in the eight isolates that contain grdA were
identiﬁed. The assembled genomic sequence from each of these isolates was queried
for plasmid sequences using PlasmidFinder 2.1 (14). The isolates each harbor 0, 2, or 3
identiﬁable plasmids (Table 1).
To demonstrate that this gene alone is sufﬁcient to confer the resistant phenotype,
grdA was ampliﬁed, cloned, and introduced into E. coli without the other genes present
on pZJ18. The subcloned grdA gene was able to confer resistance to gentamicin. The
MICs of E. coli bearing pZJ18 or the subcloned grdA gene against gentamicin were 32
and 64 g/ml, respectively (Table 2). In comparison, disruptions of grdA via transposon
mutagenesis restored the gentamicin susceptibility to background levels. The ability of
grdA to confer resistance to other aminoglycoside antibiotics was also investigated. In
addition to the elevated resistance to gentamicin, pZJ18 and the subclone of grdA
conferred resistance to sisomicin. In contrast, grdA was unable to confer resistance to
the following aminoglycoside antibiotics: amikacin, kanamycin, spectinomycin, streptomycin, and tobramycin.
DISCUSSION
The work presented here represents an application of existing comparative genomics tools to identify and begin to characterize a novel ARG. In addition to identifying the
November 2020 Volume 64 Issue 11 e00867-20
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FIG 1 Map of pZJ18, including functional annotation of encoding genes and homology to known
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TABLE 1 Plasmids present in eight isolates containing grdA identiﬁed using PlasmidFinder
2.1
Isolate
N29351

Plasmid detecteda
1. Col
2. IncI1-I

Accession no.b
1. KU674895
2. AP005147

N31844

1. IncHI2
2. IncH12A

1. BX664015
2. BX664015

N32755

1. IncFIB
2. IncFII

1. CP001919
2. CP001919

N32779
N46827

None
None

NA
NA

N46855

1. Col
2. IncQ1

1. KU674895
2. M28829

N51271

1. IncHI2
2. IncH12A
3. IncI1-1

1. BX664015
2. BX664015
3. AP005147

N51292

1. IncHI2
2. IncH12A

1. BX664015
2. BX664015

bBest

of plasmid.
BLAST match. NA, not applicable.

grdA gene, the genomic context ﬂanking this gene suggests its ability to spread. Of the
eight isolates harboring this gene, one contains the gene on the pZJ18 plasmid, and the
others potentially harbor this gene on a different plasmid or within their chromosomes.
One isolate within this study also bears a plasmid that is identical to a part of pZJ18 but
lacks the grdA gene. Taken together, these data suggest that grdA is an ARG located on
a mobile genetic element that can move from one genetic context to another, giving
it increased potential to spread through horizontal gene transfer.
Current detection strategies that either use ARG databases to identify resistant
bacteria or use sequence-independent strategies have limitations that are well documented (reviewed in reference 15). Now that phenotypic and genomic information is
being generated more routinely in ARG surveillance, it is easier to identify GSPR strains
as candidates for alternative approaches to identify novel ARGs. These include machine
learning approaches, as well as the comparative genomics strategy used in this study
(16). Given the increasing abundance of paired WGS and phenotypic data sets that are
made publicly available every day, this study demonstrates the utility of combining the
data for identiﬁcation of novel ARGs in a wide variety of samples. Ultimately, studies like
this one will contribute to that knowledgebase and improve the ability to recognize
ARGs in a sample. This will be increasingly important as sequencing technologies

TABLE 2 MIC of each aminoglycoside antibiotic determined via 2-fold broth serial dilution
method
MIC (g/ml)a
Antibiotic
Gentamicin
Sisomicin
Amikacin
Kanamycin
Spectinomycin
Streptomycinb
Tobramycin

Control
⬍0.5
⬍0.5
⬍0.5
0.5
4
⬍0.5
⬍0.5

pZJ18
32
32
⬍0.5
0.5
4
⬍0.5
⬍0.5

grdA TA clone
64
128
⬍0.5
0.5
4
0.5
0.5

aMICs

for all antibiotics except streptomycin were determined using the EPI300 strain of E. coli with
unmodiﬁed cells as the control.
bMIC values determined in the DH5␣ strain of E. coli with unmodiﬁed cells as the control.
November 2020 Volume 64 Issue 11 e00867-20
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MATERIALS AND METHODS
Genomic data and annotation. WGS data pertaining to the Salmonella isolates were downloaded
from GenBank using BioProject accession number PRJNA242614 (7). The assembled sequences within
that data set were annotated using Prokka (18). The six GSPR isolates used in this study were N29351,
N32755, N32779, N46827, N46855, and N51271. All six isolates were recovered from NARMS retail turkey
between 2011 and 2013.
Pangenome creation and interrogation. Roary was used to create a pangenome from the annotated assemblies generated by Prokka (19). To identify potentially novel gentamicin resistance genes, the
pangenome was queried to identify genes that distinguished the GSPR isolates from those that were not
resistant to gentamicin according to the Roary user manual.
Gentamicin resistance plasmid discovery. Total DNA was extracted from isolate N46855 using the
DNeasy blood and tissue kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions. That
DNA was used to transform E. coli strain EPI300 (Lucigen, Madison, WI). The resulting transformants were
selected for growth on LB supplemented with 10 g/ml gentamicin. Plasmid DNA was recovered from
one of the resulting colonies using the Qiagen miniprep kit according to the manufacturer’s instructions.
This plasmid, which contains the grdA gene and confers gentamicin resistance, was named pZJ18.
Transposon mutagenesis and sequencing. Plasmid DNA was randomly mutagenized using the
Entraceposon (CamR-3) transposon from the Template Generation System II kit according to the
manufacturer’s instructions (Thermo Scientiﬁc). The seqE and seqW primers provided in the kit were used
in Sanger sequencing reactions to sequence DNA directly adjacent to the transposon insertions. All
sequencing was done at the University of Minnesota Genomics Center.
Cloning the gentamicin resistance gene. The candidate gene was ampliﬁed via PCR using Taq
polymerase and the primers gentRsalmonellaF-TGTGTAGCGGTTTCGGTTTTATTG and gentRsalmonellaRTCTAGATGGAATACAGGTGGATAATCA. The template was genomic DNA from isolate N46855. The resulting 693-bp product was cloned into the pGEM-EZT TA cloning vector (Promega, Madison, WI) and
introduced into the EPI300 strain of E. coli via standard methods.
MIC analysis. MICs were determined using a 2-fold broth serial dilution method (20).
Plasmid annotation. The full sequence of pZJ18 was annotated using a combination of Prokka,
GeneMark, BLAST, and SeqBuilder (DNAStar, Madison, WI) (18, 21, 22). The sequence data have been
deposited in GenBank and are available using accession no. MT246861 (23).
November 2020 Volume 64 Issue 11 e00867-20
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continue to improve and sequence-based analyses increasingly replace phenotypic
analyses.
The grdA gene identiﬁed in this study confers resistance to gentamicin; however,
the mechanism of resistance remains unknown. Preliminary bioinformatic analysis
of the encoded protein revealed the presence of the Walker A motif and indicated
that the encoded protein likely binds to ATP. Future work will focus on determining
the importance of this predicted function, among other possibilities, to characterize
the biochemical advantage this protein affords the host bacterium that leads to
gentamicin resistance.
During preparation of the manuscript, a study was published in which the novel
gentamicin resistance gene gar was identiﬁed (17). A BLAST of the Gar protein against
GrdA revealed 50% identity between the two proteins. The homologous regions
include the Walker A domain and the DXD domain, expected to be critical to the
function of Gar, and therefore likely GrdA as well. In addition to their sequence-based
similarities, the spectrum of resistance conferred by grdA is consistent with the reported
spectrum of resistance for gar. Although the proteins likely confer resistance in the
same way, they differ in their ecological contexts. gar was found to be associated with
class 1 integrons, whereas grdA was not associated with this type of mobile genetic
element. grdA was instead found on a mobile genetic element that is present in both
plasmid and chromosomal contexts. The importance of this difference is highlighted by
experiments aimed at demonstrating the propensity for these genes to participate in
horizontal gene transfer. Published attempts to mobilize the integron containing gar
from its Pseudomonas host into E. coli were unsuccessful. Conversely, the pZJ18 plasmid
containing grdA was readily moved from its Salmonella host into E. coli, demonstrating
the propensity for this resistance gene to move between species. These ﬁndings do not
imply an inability of gar to participate in horizontal gene transfer. The ﬁnding of gar in
different host species provides evidence to the contrary. Whereas its presence on
integrons provides a plausible mechanism for mobility, a plasmid responsible for
horizontal transfer has not yet been identiﬁed. Continued work is needed to further
characterize the similarities and differences between these two novel resistance determinants.
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